Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.
Institute of Molecular Biology and Genetics of NASU, Kyiv, Ukraine.
Adv Exp Med Biol. 2021;1352:159-172. doi: 10.1007/978-3-030-85109-5_10.
INTRODUCTION: The emergence of a new member of the Coronaviridae family, which caused the 2020 pandemic, requires detailed research on the evolution of coronaviruses, their structure and properties, and interaction with cells. Modern nanobiotechnologies can address the many clinical challenges posed by the COVID-19 pandemic. In particular, they offer new therapeutic approaches using biocompatible nanostructures with "specific" antiviral activity. Therefore, the nanosized spherical-like molecule (0.72 nm in diameter) composed of 60 carbon atoms, C fullerene, is of interest in terms of fighting coronaviruses due to its high biological activity. In here, we aim to evaluate the effectiveness of anticoronavirus action of water-soluble pristine C fullerene in the model and in vitro systems. As a model, apathogenic for human coronavirus, we used transmissible gastroenteritis virus of swine (TGEV), which we adapted to the BHK-21 cell culture (kidney cells of a newborn Syrian hamster). METHODS: The shape and size of the particles present in C fullerene aqueous colloidal solution (CFAS) of given concentration, as well as CFAS stability (value of zeta potential) were studied using microscopic (STM, scanning tunneling microscopy, and AFM, atomic force microscopy) and spectroscopic (DLS, dynamic light scattering) methods. The cytopathic effect of TGEV was determined with the help of a Leica DM 750 microscope and the degree of monolayer changes in cells was assessed. The microscopy of the viral suspension was performed using a high resolution transmission electron microscope (HRTEM; JEM-1230, Japan). Finally, the search for and design of optimal possible complexes between C fullerene and target proteins in the structure of SARS-CoV-2 coronavirus, evaluation of their stability in the simulated cellular environment were performed using molecular dynamics and docking methods. RESULTS: It was found that the maximum allowable cytotoxic concentration of C fullerene is 37.5 ± 3.0 μg/ml. The investigated CFAS reduces the titer of coronavirus infectious activity by the value of 2.00 ± 0.08 TCID/ml. It was shown that C fullerene interacts directly with SARS-CoV-2 proteins, such as RdRp (RNA-dependent RNA polymerase) and 3CLpro (3-chymotrypsin-like protease), which is critical for the life cycle of the coronavirus and, thus, inhibits its functional activity. In both cases, C fullerene fills the binding pocket and gets stuck there through stacking and steric interactions. CONCLUSION: Pioneer in vitro study to identify the anticoronavirus activity of water-soluble pristine C fullerenes indicates that they are highly promising for further preclinical studies, since a significant inhibition of the infectious activity of swine coronavirus of transmissible gastroenteritis in BHK-21 cell culture was found. According to molecular modeling results, it was shown that C fullerene can create the stable complexes with 3CLpro and RdRp proteins of SARS-CoV-2 coronavirus and, thus, suppress its functional activity.
简介:冠状病毒家族的一个新成员的出现,导致了 2020 年的大流行,这需要对冠状病毒的进化、结构和特性,以及与细胞的相互作用进行详细研究。现代纳米生物技术可以解决 COVID-19 大流行带来的许多临床挑战。特别是,它们提供了使用具有“特异性”抗病毒活性的生物相容性纳米结构的新的治疗方法。因此,由于其高生物活性,由 60 个碳原子组成的、纳米级的、球状的(直径 0.72nm)分子 C60 富勒烯在对抗冠状病毒方面具有吸引力。在这里,我们旨在评估水相富勒烯在模型和体外系统中抗冠状病毒作用的有效性。作为一种模型,我们使用了一种对人类冠状病毒无致病性的传染性胃肠炎病毒(TGEV),我们将其适应了 BHK-21 细胞培养(新生叙利亚仓鼠的肾细胞)。
方法:使用显微镜(STM,扫描隧道显微镜和 AFM,原子力显微镜)和光谱(DLS,动态光散射)方法研究了给定浓度的 C60 富勒烯水胶体溶液(CFAS)中存在的颗粒的形状和大小,以及 CFAS 的稳定性(zeta 电位值)。借助 Leica DM 750 显微镜确定了 TGEV 的细胞病变效应,并评估了细胞单层变化的程度。使用高分辨率透射电子显微镜(HRTEM;JEM-1230,日本)对病毒悬浮液进行了显微镜检查。最后,使用分子动力学和对接方法对 SARS-CoV-2 冠状病毒结构中 C60 富勒烯与靶蛋白之间的最佳可能复合物进行了搜索和设计,并评估了它们在模拟细胞环境中的稳定性。
结果:发现 C60 富勒烯的最大允许细胞毒性浓度为 37.5±3.0μg/ml。研究的 CFAS 将冠状病毒感染性活性的滴度降低了 2.00±0.08TCID/ml。结果表明,C60 富勒烯直接与 SARS-CoV-2 蛋白相互作用,如 RdRp(RNA 依赖性 RNA 聚合酶)和 3CLpro(3-糜蛋白酶样蛋白酶),这对于冠状病毒的生命周期至关重要,因此抑制了其功能活性。在这两种情况下,C60 富勒烯都填充了结合口袋,并通过堆积和空间位阻相互作用卡在那里。
结论:这是首例鉴定水溶性原始 C60 富勒烯抗冠状病毒活性的体外研究,表明它们具有很高的临床前研究潜力,因为在 BHK-21 细胞培养中发现了对传染性胃肠炎猪冠状病毒的感染性活性的显著抑制。根据分子建模结果,表明 C60 富勒烯可以与 SARS-CoV-2 冠状病毒的 3CLpro 和 RdRp 蛋白形成稳定的复合物,并抑制其功能活性。
Sci Rep. 2021-9-7
Oxid Med Cell Longev. 2020-2-13
Int J Obes (Lond). 2018-1-30
Microbiol Spectr. 2023-6-15
Nat Commun. 2019-5-28
J Nanosci Nanotechnol. 2019-4-1
Nanoscale Res Lett. 2017-12
J Comput Chem. 2013-7-6
J Comput Chem. 2011-5-3
J Am Vet Med Assoc. 1946-4